1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Bayer

Anonymous board for Bayer.


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    30
    Views:
    8,470
  2. anonymous
    Replies:
    3
    Views:
    1,260
  3. anonymous
    Replies:
    7
    Views:
    2,766
  4. anonymous
    Replies:
    148
    Views:
    18,715
  5. anonymous
    Replies:
    50
    Views:
    6,420
  6. anonymous
    Replies:
    8
    Views:
    1,362
  7. anonymous
    Replies:
    4
    Views:
    1,128
  8. anonymous
    Replies:
    38
    Views:
    9,957
  9. anonymous
    Replies:
    4
    Views:
    1,011
  10. anonymous
    Replies:
    5
    Views:
    1,227
  11. anonymous
    Replies:
    9
    Views:
    1,790
  12. anonymous
    Replies:
    4
    Views:
    958
  13. anonymous
    Replies:
    14
    Views:
    4,181
  14. anonymous
    Replies:
    19
    Views:
    4,365
  15. anonymous
    Replies:
    0
    Views:
    803
  16. anonymous
    Replies:
    15
    Views:
    6,962
  17. anonymous
    Replies:
    28
    Views:
    5,103
  18. Save us Sebastian
    Replies:
    36
    Views:
    4,728
  19. anonymous
    Replies:
    0
    Views:
    532
  20. anonymous
    Replies:
    1
    Views:
    1,167

Thread Display Options

Loading...